Avanos Medical
AVNS
359 hedge funds and large institutions have $1.54B invested in Avanos Medical in 2016 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 88 increasing their positions, 111 reducing their positions, and 46 closing their positions.
324% more call options, than puts
Call options by funds: $6.58M | Put options by funds: $1.55M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 46
10% more capital invested
Capital invested by funds: $1.4B → $1.54B (+$142M)
0% more funds holding
Funds holding: 358 → 359 (+1)
21% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 111
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$34.3M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$13.9M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$12.3M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.8M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$9.86M |
Top Sellers
AVNS Hedge Fund Activity: Q4 2016 in Review
359 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2016, worth a combined $1.54B — up 10% from $1.4B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new AVNS positions and 46 closed out — a net gain of 6 holders — while 88 added to existing stakes and 111 trimmed.
The largest buyer was Invesco, adding an estimated $34.3M. The largest seller was Victory Capital Management, exiting entirely with an estimated $25.6M sold.
- 359 institutional investors held Avanos Medical (AVNS) as of Q4 2016, up from 358 in Q3 2016.
- Funds reported $1.54B of Avanos Medical stock for Q4 2016, up 10% quarter-over-quarter.
- 52 funds opened new Avanos Medical positions in Q4 2016 and 46 closed out, a net change of +6 holders.
- The largest Avanos Medical buyer in Q4 2016 was Invesco, an estimated $34.3M added.
- The largest Avanos Medical seller in Q4 2016 was Victory Capital Management, an estimated $25.6M sold.
Based on aggregated 13F filings for Q4 2016.